Page last updated: 2024-08-23

5'-palmitoyl cytarabine and cytarabine

5'-palmitoyl cytarabine has been researched along with cytarabine in 12 studies

*Cytarabine: A pyrimidine nucleoside analog that is used mainly in the treatment of leukemia, especially acute non-lymphoblastic leukemia. Cytarabine is an antimetabolite antineoplastic agent that inhibits the synthesis of DNA. Its actions are specific for the S phase of the cell cycle. It also has antiviral and immunosuppressant properties. (From Martindale, The Extra Pharmacopoeia, 30th ed, p472) [MeSH]

*Cytarabine: A pyrimidine nucleoside analog that is used mainly in the treatment of leukemia, especially acute non-lymphoblastic leukemia. Cytarabine is an antimetabolite antineoplastic agent that inhibits the synthesis of DNA. Its actions are specific for the S phase of the cell cycle. It also has antiviral and immunosuppressant properties. (From Martindale, The Extra Pharmacopoeia, 30th ed, p472) [MeSH]

Research

Studies (12)

TimeframeStudies, this research(%)All Research%
pre-199012 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
An, SH; Berdel, WE; Buchheit, DJ; Hong, CI; Kirisits, AJ; Nechaev, A; West, CR1
Domae, N; Kagawa, D; Nakamura, T; Sasada, M; Sugiyama, M; Uchida, M; Uchino, H; Ueda, T; Ueda, Y1
Horiike, S; Horiuchi, H; Iwamoto, K; Kitani, K; Kobayashi, Y; Kondo, M; Maruo, N; Misawa, S; Mizuno, T; Ozawa, M1
Kimura, K; Ohno, R1
Hattori, K; Hirano, M; Hoshino, A; Ito, M; Kimura, K; Maekawa, T; Miura, Y; Nakamura, T; Ohno, R; Ota, K1
Yamada, K2
Hartmann, HR; Hengartner, H; Rubas, W; Schott, H; Schwendener, R; Supersaxo, A; Weder, HG1
Kubota, Y; Masaoka, T; Nakamura, H; Oguma, S; Shibata, H; Takubo, T; Tani, Y; Ueda, T1
Hori, K; Naganuma, K; Sakurai, Y; Tsukagoshi, S; Tsuruo, T1
Hori, K; Sakurai, Y; Tsukagoshi, S; Tsuruo, T1
Hori, K; Iida, H; Sakurai, Y; Tsukagoshi, S; Tsuruo, T1

Reviews

1 review(s) available for 5'-palmitoyl cytarabine and cytarabine

ArticleYear
[Symposium on treatment of cancer. 1. Chemotherapy of acute leukemia in adults].
    Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, 1984, Volume: 73, Issue:11

    Topics: Aclarubicin; Acute Disease; Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Agents; Clinical Trials as Topic; Cytarabine; Doxorubicin; Humans; Interferon Type I; Leukemia; Middle Aged; Naphthacenes

1984

Trials

1 trial(s) available for 5'-palmitoyl cytarabine and cytarabine

ArticleYear
[Symposium on treatment of cancer. 1. Chemotherapy of acute leukemia in adults].
    Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, 1984, Volume: 73, Issue:11

    Topics: Aclarubicin; Acute Disease; Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Agents; Clinical Trials as Topic; Cytarabine; Doxorubicin; Humans; Interferon Type I; Leukemia; Middle Aged; Naphthacenes

1984

Other Studies

11 other study(ies) available for 5'-palmitoyl cytarabine and cytarabine

ArticleYear
Nucleoside conjugates. 7. Synthesis and antitumor activity of 1-beta-D-arabinofuranosylcytosine conjugates of ether lipids.
    Journal of medicinal chemistry, 1986, Volume: 29, Issue:10

    Topics: Animals; Antineoplastic Agents; Cells, Cultured; Cytarabine; Drug Administration Schedule; Humans; Leukemia L1210; Leukemia P388; Mice; Mice, Inbred DBA; Solubility

1986
Clinical pharmacology of N4-palmitoyl-1-beta-D-arabinofuranosylcytosine in patients with hematologic malignancies.
    Cancer chemotherapy and pharmacology, 1989, Volume: 24, Issue:6

    Topics: Adult; Aged; Antineoplastic Agents; Arabinofuranosyluracil; Cytarabine; Female; Hematologic Diseases; Humans; Leukemia; Male; Middle Aged; Polycythemia Vera

1989
[Successful treatment of chronic myelomonocytic leukemia (CMMoL) with N4-palmitoyl-1-beta-D-arabinofuranosylcytosine (PLAC)].
    [Rinsho ketsueki] The Japanese journal of clinical hematology, 1988, Volume: 29, Issue:12

    Topics: Aged; Antineoplastic Agents; Chromosome Inversion; Chromosomes, Human, Pair 1; Cytarabine; Hematopoietic Stem Cells; Humans; Karyotyping; Leukemia, Myelomonocytic, Chronic; Male; Remission Induction

1988
[Treatment of myelodysplastic syndromes (MDS) with oral administration of N4-palmitoyl-1-beta-D-arabinofuranosyl cytosine (PLAC)].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1988, Volume: 15, Issue:4 Pt 2-2

    Topics: Administration, Oral; Adult; Aged; Anorexia; Antineoplastic Agents; Cytarabine; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Myelodysplastic Syndromes; Nausea

1988
Phase I clinical and pharmacokinetic study of orally administered N4-palmitoyl-1-beta-D-arabinofuranosylcytosine.
    Medical oncology and tumor pharmacotherapy, 1987, Volume: 4, Issue:2

    Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Anorexia; Antineoplastic Agents; Bone Marrow; Cytarabine; Drug Administration Schedule; Drug Evaluation; Female; Humans; Leukocyte Count; Male; Middle Aged; Nausea; Neoplasms

1987
Chemotherapy of acute leukemia in adults.
    Japanese journal of medicine, 1985, Volume: 24, Issue:1

    Topics: Aclarubicin; Acute Disease; Adult; Antineoplastic Agents; Cytarabine; Doxorubicin; Drug Evaluation; Humans; Interferon Type I; Leukemia; Naphthacenes

1985
Treatment of murine L1210 lymphoid leukemia and melanoma B16 with lipophilic cytosine arabinoside prodrugs incorporated into unilamellar liposomes.
    International journal of cancer, 1986, Jan-15, Volume: 37, Issue:1

    Topics: Animals; Bone Marrow; Cytarabine; Female; Leukemia L1210; Liposomes; Melanoma; Mice; Mice, Inbred C57BL; Mice, Inbred DBA

1986
Phase I and early phase II study of PL-AC [N4-palmitoyl-(1-beta-D-arabinofuranosyl) cytosine] on hematopoietic malignancies.
    Nihon Gan Chiryo Gakkai shi, 1984, Feb-20, Volume: 19, Issue:1

    Topics: Adolescent; Adult; Child; Cytarabine; Drug Administration Schedule; Drug Evaluation; Female; Humans; Leukemia; Leukemia, Lymphoid; Leukemia, Myeloid, Acute; Lymphoma; Male; Middle Aged

1984
Antitumor effects and pharmacology of orally administered N4-palmitoyl-1-beta-D-arabinofuranosylcytosine in mice.
    Cancer research, 1984, Volume: 44, Issue:1

    Topics: Adenocarcinoma; Administration, Oral; Animals; Colonic Neoplasms; Cytarabine; Drug Evaluation, Preclinical; Leukemia L1210; Leukemia P388; Lung Neoplasms; Male; Mammary Neoplasms, Experimental; Melanoma; Mice; Mice, Inbred C57BL; Mice, Inbred Strains; Neoplasms, Experimental

1984
Purification and characterization of an amidohydrolase for N4-long-chain fatty acyl derivatives of 1-beta-D-arabinofuranosylcytosine from mouse liver microsomes.
    Cancer research, 1984, Volume: 44, Issue:3

    Topics: Amidohydrolases; Animals; Cytarabine; Kinetics; Male; Mice; Mice, Inbred Strains; Microsomes, Liver; Molecular Weight; Protease Inhibitors; Substrate Specificity; Sulfhydryl Compounds

1984
Membrane affinity and metabolism of N4-palmitoyl-1-beta-D-arabinofuranosylcytosine into cultured KB cells.
    Cancer research, 1981, Volume: 41, Issue:11 Pt 1

    Topics: Animals; Cell Fractionation; Cell Line; Cell Membrane; Cell Nucleus; Centrifugation, Density Gradient; Chromatography, Paper; Chromatography, Thin Layer; Cytarabine; Cytoplasm; Palmitates

1981